Effect of Vaccination with Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays as Predictors of Protection

In order to plan for the wide-scale introduction of meningococcal C conjugate (MCC) vaccine for United Kingdom children up to 18 years old, phase II trials were undertaken to investigate whether there was any interaction between MCC vaccines conjugated to tetanus toxoid (TT) or a derivative of dipht...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Burrage, Moya, Robinson, Andrew, Borrow, Ray, Andrews, Nick, Southern, Joanna, Findlow, Jamie, Martin, Sarah, Thornton, Carol, Goldblatt, David, Corbel, Michael, Sesardic, Dorothea, Cartwight, Keith, Richmond, Peter, Miller, Elizabeth
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2002
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC128295/
https://ncbi.nlm.nih.gov/pubmed/12183540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.9.4946-4954.2002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares